标题 |
Exploratory biomarker analysis of trastuzumab deruxtecan (T-DXd) vs physician’schoice of chemotherapy (TPC) in HER2-low/ultralow, hormone receptor–positive(HR+) metastatic breast cancer (mBC) in DESTINY-Breast06 (DB-06)
DESTINY-Breast06(DB-06)中HER2低/超低、激素受体阳性(HR+)转移性乳腺癌(mBC)中曲妥珠单抗deruxtecan(T-DXd)与医生选择化疗(TPC)的探索性生物标志物分析
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 | asco |
求助人 | |
下载 | 暂无链接,等待应助者上传 |